Free Trial
→ Financial legend: “This is bad, really bad...” (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$76.60
+7.8%		$77.07
$70.39
▼
$101.40
$11.69B0.981.31 million shs3.66 million shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$64.14
+0.2%		$69.01
$38.91
▼
$147.03
$1.93B0.67779,192 shs521,588 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$321.55
+0.7%		$320.29
$262.94
▼
$362.41
$12.71B0.71415,224 shs251,281 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+8.40%-3.68%+2.57%-10.02%-8.80%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+0.09%-5.01%-6.91%+8.25%-21.44%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.69%+0.10%+0.71%-1.42%+20.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$76.60
+7.8%		$77.07
$70.39
▼
$101.40
$11.69B0.981.31 million shs3.66 million shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$64.14
+0.2%		$69.01
$38.91
▼
$147.03
$1.93B0.67779,192 shs521,588 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$321.55
+0.7%		$320.29
$262.94
▼
$362.41
$12.71B0.71415,224 shs251,281 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+8.40%-3.68%+2.57%-10.02%-8.80%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+0.09%-5.01%-6.91%+8.25%-21.44%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.69%+0.10%+0.71%-1.42%+20.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.75
Moderate Buy$96.0825.43% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.10
Hold$71.2411.06% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$367.0714.16% Upside

Current Analyst Ratings Breakdown

Latest GMED, INSP, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/9/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$100.00 ➝ $90.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingNeutral
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$115.00 ➝ $105.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$99.00 ➝ $100.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$117.00 ➝ $100.00
11/6/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeOutperform ➝ Market Perform$94.00 ➝ $78.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingHold$78.00 ➝ $76.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetEqual Weight$56.00 ➝ $69.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$60.00 ➝ $65.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetUnderweight$65.00 ➝ $62.00
11/3/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$73.00 ➝ $77.00
(Data available from 11/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.94B3.50$5.53 per share13.86$33.86 per share2.26
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M2.04$2.76 per share23.26$28.55 per share2.25
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B9.03$4.29 per share75.01$40.18 per share8.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.0717.7014.191.4017.02%14.57%12.62%N/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$3.4432.8142.484.8711.43%7.32%6.39%N/A
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$3.9781.6352.542.2210.06%10.39%8.09%N/A

Latest GMED, INSP, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.20$1.23+$0.03$1.04$792.39 million$763.72 million
11/2/2026Q3 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.0870$0.14+$0.0530-$0.84$204.31 million$206.70 million
10/29/2026Q3 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.20$1.07-$0.13$1.07$401.41 million$410.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.62
2.93
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.45
6.16
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.89
3.92

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000134.26 million109.59 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.97 million28.33 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.41 million38.27 millionOptionable

Recent News About These Companies

Boston Scientific stock faces negative outlook as growth slows
November 9 at 8:36 PM  |  ad-hoc-news.deA
Penumbra, Inc. (NYSE:PEN) Stock Now Rated "Hold" by Wall Street Brokerages
November 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31174871
Penumbra, Inc. (NYSE:PEN) Stock Rated "Hold" by Wall Street Brokerages
November 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-penumbra-inc-nyse-pen-stock-rated-hold-by-wall-street-brokerages-2026-11-03/
Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny
October 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/penumbra-pen-stock-faces-q3-141345790.html
Penumbra, Inc. reports third quarter 2026 revenue of $410.1 million
October 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/penumbra-inc-reports-third-quarter-2026-revenue-of-410-1-million/ar-AA2goJ4J
Penumbra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
October 29, 2026  |  marketscreener.comM
Penumbra Inc. Q3 Income Drops
October 29, 2026  |  rttnews.comhttps://www.rttnews.com/3705741/penumbra-inc-q3-income-drops.aspx
Penumbra (NYSE:PEN) Announces Quarterly Earnings Results
October 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/earnings-penumbra-nyse-pen-announces-quarterly-earnings-results-2026-10-29/
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
October 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/penumbra-inc-reports-third-quarter-2026-financial-results-302922852.html
Penumbra (NYSE:PEN) Stock Price Crosses Below Fifty Day Moving Average - What's Next?
October 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-penumbra-nyse-pen-stock-price-crosses-below-fifty-day-moving-average-whats-next-2026-10-29/
Apollon Wealth Management LLC Sells 3,811 Shares of Penumbra, Inc. $PEN
October 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-apollon-wealth-management-llc-sells-3811-shares-of-penumbra-inc-pen-2026-10-29/
Penumbra, Inc Receives FDA Clearance For Lightning Computer Assisted Vacuum Thrombectomy Technology For The Treatment Of Deep Vein Thrombosis
October 21, 2026  |  marketscreener.comM
MarketBeat cites USD 367.07 target for Penumbra stock
October 20, 2026  |  ad-hoc-news.deA
Penumbra, Inc.: Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
October 20, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-10/69885611-penumbra-inc-penumbra-s-cavt-technology-receives-fda-clearance-for-the-treatment-of-deep-vein-thrombosis-dvt-008.htm
Penumbra’s CAVT Technology Cleared for DVT Indication
October 20, 2026  |  evtoday.comE
Penumbra Says FDA Clears CAVT Technology for Deep Vein Thrombosis
October 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/penumbra-says-fda-clears-cavt-142033945.html
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
October 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/penumbras-cavt-technology-receives-fda-130000245.html
Life Sciences Antitrust Quarterly Update Q3 2026
October 19, 2026  |  jdsupra.comhttps://www.jdsupra.com/legalnews/life-sciences-antitrust-quarterly-8478539/
Penumbra (NYSE:PEN) Stock Breaks Above 50-Day Moving Average - Should You Sell?
October 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-penumbra-nyse-pen-stock-breaks-above-50-day-moving-average-should-you-sell-2026-10-17/
BOLT-DVT Evaluates CAVT With Penumbra’s Indigo Aspiration System
October 16, 2026  |  evtoday.comE
RBC Capital Keeps Their Hold Rating on Penumbra (PEN)
October 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PEN/pressreleases/4946992/rbc-capital-keeps-their-hold-rating-on-penumbra-pen/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
White Tesla sports car parked at a launch site with rocket boosters visible against a sunset sky.
Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
By Sam Quirke | October 19, 2026
Salesforce cloud logo in a futuristic tech setting, highlighting CRM enterprise software and AI platform growth.
Salesforce Fuels AI Engine With $5.66B Braze Buyout
By Jeffrey Neal Johnson | October 21, 2026
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
Industrial energy facility with cooling units, piping systems, and a large turbine beside flowing water.
These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
By Chris Markoch | October 18, 2026
A football helmet, poker chips, basketball, and a smartphone displaying a sports betting app on a dark table.
Did Promo Spending Actually Win Back Bettors for These 3 Gambling Stocks?
By Dan Schmidt | October 12, 2026
Globus Medical stock logo

Globus Medical NYSE:GMED

$76.60 +5.55 (+7.82%)
Closing price 11/9/2026 03:59 PM Eastern
Extended Trading
$76.65 +0.05 (+0.06%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$64.14 +0.16 (+0.25%)
Closing price 11/9/2026 03:59 PM Eastern
Extended Trading
$62.99 -1.15 (-1.79%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Penumbra stock logo

Penumbra NYSE:PEN

$321.55 +2.34 (+0.73%)
Closing price 11/9/2026 03:59 PM Eastern
Extended Trading
$321.85 +0.30 (+0.09%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas